Award
Delivery Order #SPE2D326F6873
Pfizer Inc. Delivery Order for Provera Tablets under Military Pharmaceutical IDV
Buyer
Defense Logistics Agency
Award Amount
$195.95
Ceiling
$195.95
Awarded
March 02, 2026
Period of Performance
Mar 02, 2026 – Mar 03, 2026
Identifier
SPE2D326F6873
NAICS
325412
This award is a delivery order contract issued under an existing indefinite delivery vehicle (IDV) agreement with Pfizer Inc., a leading pharmaceutical manufacturer and distributor. The delivery order procures Provera 2.5 mg tablets, a critical medication, to support military health needs. This contract highlights Pfizer's ongoing role in supplying essential pharmaceuticals to the Department of Defense, ensuring the readiness and well-being of military personnel. The scope involves the timely delivery of specified pharmaceutical products at the New York performance location within a short, defined timeframe. The award follows a competitive process established in the parent IDV contract, which underpins a multi-year, robust partnership for military medical supply provision. This delivery order builds upon Pfizer’s prior long-term contract to manufacture and distribute essential medicines, reinforcing the strategic importance of these supplies to defense health operations.
Description
4571000059!PROVERA 2.5 MG TABLET 100S